Research programme: therapeutic agents - BioSeek/Ono
Latest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator BioSeek; Ono Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Undefined in Japan
- 04 Nov 2017 No recent reports of development identified for research development in Undefined in USA
- 01 Dec 2011 Early research is ongoing in the USA & Japan